预测转移性割抗性前列腺癌患者的存活率:开发预后性诺莫图
Xingyue Huo1, Manish Kohli1, Joseph Finkelstein1
1University of Utah, Salt Lake City, UT, USA.
Studies in health technology and informatics
|April 9, 2025
概括
这项研究开发了转移性割抵抗性前列腺癌 (mCRPC) 患者的整体生存预测名录. 该工具准确地预测了生存率,有助于对这种具有挑战性的癌症的治疗决策.
科学领域:
- 在瘤学瘤学.
- 医学统计 医学统计
- 预测 预测 预测 预测 预测
背景情况:
- 转移性割抵抗性前列腺癌 (mCRPC) 存在重大生存挑战,其5年生存率约为30%.
- 准确的生存预测对于在mCRPC患者中定制治疗策略至关重要.
研究的目的:
- 在常规的临床环境中开发和验证一个名谱来预测mCRPC患者的整体存活率.
主要方法:
- 使用考克斯的比例危险模型来确定生存的预测因素.
- 关键预测因素包括治疗组,性酸酶 (ALP),乳酸脱酶 (LDH),专蛋白,血红蛋白和前列腺特异性抗原 (PSA).
- 模型性能使用一致性指数 (C指数) 和曲线下的面积 (AUC) 进行评估,并通过引导进行内部验证.
主要成果:
- 升高的ALP,LDH和PSA,以及降低的白蛋白和血红蛋白,与增加的死亡风险有显著的关联.
- 开发的诺米图表表显示出良好的预测准确度,达到0.637.7的C指数.
- 诺米图的AUC值分别为0.736,0.686和0.712对于1年,2年和3年的生存预测.
- 校准图片证实了预测和观察到的生存率之间的强烈一致.
结论:
- 开发的诺米图谱为预测mCRPC患者的整体存活率提供了可靠的工具.
- 这种预后模型可以有效地集成到临床实践中,以指导患者管理和治疗选择.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
185
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12.9K
相关概念视频
01:21Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
01:24Kaplan-Meier Approach
60
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
60